Phisiopathogenesis, epidemiology and laboratory diagnosis of candidemia;Fisiopatogenia, epidemiologia e diagnóstico laboratorial da candidemia

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 46, Issue 3, 2010, Pages 225-234

  Giolo, Muriel Padovani ^a   Svidzinski, Terezinha Inez Estivalet ^b  

^a UNIVERSIDADE PARANAENSE   (Brazil)

^b Biocências Aplicadas à Farmácia   (Brazil)

Author keywords

Candidemia; Genotyping; Pathogenicity; Virulence factors

Indexed keywords

EID: 77956555900     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/s1676-24442010000300009     Document Type: Article

References (64)

1. ABI-SAID, D. et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis, v. 24, p. 1122-8, 1997. (Pubitemid 127774267)
2. AHMAD, S et al. Seminested PCR for diagnosis of candidemia: comparison with cultre, antigen detection, and biochemical methods for species identification. J Clin Microbiol, v. 40, p. 2483-9, 2002.
3. ALMEIDA, O. P.; SCULLY, P. Fungal infections of the mouth. Braz J Oral Sci, v. 1, p. 19-26, 2002.
4. ALONSO-VALLE, H. et al. Candidemia in terciary care hospital: epidemiology and factors influencing motality. Europ Clin Microbiol Infect Dis, v. 22, p. 254-7, 2003.
5. ARMSTRONG, D. Problems in management of opportunistic fungal diseases. Rev Infect Dis, v. 2, p. 1591-9, 1989.
6. BLOT, S. I. et al. Effects of nosocomial candidemia on outcomes of critically Ill patients. The Americ J of Med, v. 113, p. 480-5, 2002.
7. CALDERONI, R. A.; FONZI, W. A. Virulence factors of Candida albicans. Trends in Microbiol, v. 9, p. 327-35, 2001.
8. CHANG, M. R. et al. Candida bloodstream infection: data from a teaching hospital in Mato Grosso do Sul, Brazil. Rev Inst Med Trop, v. 50, p. 265-8, 2008.
9. COLOMBO, A. L.; GUIMARÃES, T. Epidemiology of hematogenous infections due to Candida spp. Rev Soc Bras Med Trop, v. 36, p. 599-607, 2003.
10. COLOMBO, A. L. et al. Epidemiology of candidemia in Brazil: nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol, v. 44, p. 2816-23, 2006.
11. COLOMBO A. L. et al. Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol, v. 28, p. 570-6, 2007.
12. CONSOLARO, M. E. L. et al. Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans. Mycopathologia, v. 159, p. 501-7, 2005.
13. CORMICAN, M. G.; PFALLER, M. A. Standardization of antifungal susceptibility testing. J Antimicrob Chemotherapy, v. 38, p. 561-78, 1996.
14. CORREA, P. C. et al. Caracterização fenotípica de leveduras isoladas da mucosa vaginal em mulheres adultas. Rev Bras Ginecol Obstet, v. 3, p. 177-81.
15. CUENCA-ESTRELLA, M. et al. Comparative evaluation of NCCLS M27-A and EUCATEST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob Agents Chemother, v. 46, p. 3644-7.
16. DAMBROSO, D. et al. Radiotherapy effect on frequency of Candida spp. and on virulence of C. albicans isolated from the oral cavity of head and neck cancer patients. Rev Ciênc Farm Básica e Apt, v. 30, p. 25-32.
17. DIGNANI, M. C; SOLOMKIN J. S.; ANAISSIE, E. Candida. In: ANAISSIE, E.; McGINNIS, M. R.; PFALLER, M. A. (Ed.). Med mycology. 1. ed. Philadelphia: Churchill Livingstone, 2003. p. 195-239.
18. DIEKEMA, J. D. et al. Evalution of E test and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole. J Clin Microbiol, v. 45, p. 1974-7, 2007.
19. DOUGLAS, J. L. Candida biofilms and their role in infection. Trends in Microbiol, v. 11, p. 30-6, 2004.
20. DUNNE, W. M. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol, v. 15, p. 155-66, 2003.
21. EDMOND, M. B. et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infec Dis, v. 29, p. 239-44, 1999.
22. EGGIMAN, P.; GARBINO, J.; PITTET, D. Epidemiology of Candida species infections in critically ill non-immunosupressed patients. Lancet Infect Dis, v. 3, p. 685-702, 2003. (Pubitemid 37345347)
23. FAVERO, D. Fator hemolítico em Candida tropicalis. Londrina, 2008. Dissertação (mestrado) - Programa de pós- graduação em Microbiologia da Universidade Estadual de Londrina.
24. FURLANETO-MAIA, L. et al. In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals. Mycopathologia, v. 166, p. 209-17, 2008.
25. GACSER, A. et al. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J Clin Invest, v. 117, p. 3049-958, 2007.
26. GUDLAUGSSON, O. et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis, v. 37, p. 1172-7, 2003.
27. HINRICHSEN, S. L. et al. Candida isolates in tertiary hospitals in northeastern Brazil. Braz J Microbiol, v. 40, p. 325-8, 2009.
28. IBRAHIM, A. S. et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun, v. 63, p. 1993-8, 1995.
29. KANAFANI, A. Z.; PERFECT, J. R. Resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis, v. 469, p. 120-8, 2007.
30. KANBE, T. et al. PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast, v. 19, p. 973-89, 2002. (Pubitemid 34918798)
31. KLEMPP-SELB, B.; RIMEK, D.; KAPPE, R. Karyotyping of Candida albicans and Candida glabrata from patients with Candida sepsis. Mycoses, v. 43, p. 159-63, 2000.
32. KUMAMOTO, C. A.; VINCES, M. D. Contributions of hyphae and hyphae-co-regulated genes to Candida albicans virulence. Cell Microbiol, v. 7, p. 1546-54, 2005.
33. KUMAR, G.; KUMAR, S. J.; MENON, T. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia, v. 161, p. 213-8, 2006.
34. LACAZ, C. S. et al. Tratado de micologia médica: LACAZ. São Paulo: Sarvier, 2002. p. 34, 125.
35. LEHMANN, P. F.; LIN, D.; LASKER, B. A. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol, v. 30, p. 3249-54, 1992.
36. LUO, G.; SAMARANAYAKE, L. P.; YAU, J. Y. Y. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol, v. 1, p. 2971-4, 2001.
37. LUO, G. et al. Reverse transcriptase polymerase chain reaction (RT-PCR) detection of HPL gene expression in Candida glabrata and its possible role in in vitro haemolysin production. APMIS, v. 112, p. 283-90, 2004.
38. MANNS, J. M.; MOSSER, D. M.; BUCKLEY, H. R. Production of a hemolytic factor by Candida albicans. Infect and Immun, v. 62, p. 5154-6, 1994.
39. MARTIN, G. S. et al. The epidemiology of sepsis in the United States from 1979 through 2000. The New Eng J Med, v. 348, p. 1546-54, 2003.
40. MIMICA, L. M. J. et al. Diagnóstico de infecção por Candida: avaliação de testes de identificação de espécies e caracterização do perfil de suscetibilidade. J Bras Patol Med Lab, v. 45, p. 17-23, 2009.
41. MOHAN, V.; BALLAL, M. Proteinase and phospholipase activity as virulence factors in Candida species isolated from blood. RevIberoam Micol, v. 25, p. 208-10, 2008.
42. NEGRI, M. et al. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia, v. 169, p. 175-82, 2010.
43. NEGRI, M. et al. Correlation between Etest, disk diffusion and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization. J Clin Lab Anal, v. 23, p. 324-30, 2009.
44. NOBILE, J. C. et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol, v. 18, p. 1017-24, 2008.
45. OBAYASHI, T. et al. Plasma (1->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet, v. 345, p. 17-20, 1995.
46. ODDS, F. C. Pathogenesis of Candida infection. J American Academic Dermatol, v. 31, p. 2-5, 1994.
47. OMBRELLA, A. M.; RACCA, L.; RAMOS, L. Actividades proteinasa y fosfolipasa de aislamientos de Candida albicans provenientes de secreciones vaginales com distintos valores de pH. Rev Iberoam Micol, v. 25, p. 12-6, 2008.
48. PÁDUA, R. A. F. et al. Adherence of Pseudomonas aeruginosa and Candida albicans to urinary catheters. Rev Iber Micol, v. 25, p. 173-5, 2008.
49. PFALLER, M. A. et al. Clinical evaluation of the sensititre yeast one colorimetrical antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin and micafungin. J Clin Microbiol, v. 46, p. 2155-9, 2008.
50. PAPPAS, P. G. et al. The NIAID Mycoses Study Group: a prospective observatinal study of candidemia, epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis, v. 37, p. 634-43. 2003.
51. RAMAGE, G. et al. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol, v. 18, p. 163-70, 2001.
52. RESENDE, J. C. P. et al. Phenotypic and genotypic identification of Candida spp. isolated from hospitalized patients. Rev Iberoam Micol, v. 21, p. 24-8, 2004.
53. REX, J. H. et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev, v. 14, p. 643-58, 2001.
54. ROILIDES, E. et al. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol, v. 41, p. 735-41, 2003.
55. RORIG, K. C. O.; COLACITE, J.; ABEGG, M. A. Produção de fatores de virulência in vitro por espécies patogênicas do gênero Candida. Rev Soc Bras Med Trop, v. 42, p. 225-7, 2009.
56. SANGUINETTI, M. et al. Evaluation of vitek 2 and rapid yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J Clin Microbiol, v. 45, p. 1343-6, 2007.
57. SIDRIM, J. J. C.; ROCHA, M. F. G. Micologia médica à luz de autores contemporâneos. Rio de Janeiro: Guanabara Koogan, 2004. p. 21, 266.
58. SOLL, D. R. Candida biofilms: is adhesion sexy? Current Biology, v. 18, p. 153-5, 2008.
59. TALARMIN, J. P. et al. Epidemiology of candidemia: a one-year prospective observational study in the west of France. Med Mal Infect, v. 39, p. 877-85, 2009.
60. TAMURA, N. K. et al. Fatores de virulência de Candida spp. isoladas de cateteres venosos e mãos de servidores hospitalares. Rev Soc Bras Med Trop, v. 40, p. 91-3, 2007.
61. VALENZA, G. et al. Evaluation of new colorimetric vitek 2 yeast identification card by use of different source media. J Clin Microbiol, v. 46, p. 3784-7, 2008.
62. VALERIO, H. M.; WEIKERT-OLIVEIRA, R. C.; RESENDE, M. A. Differentiation of Candida species obtained from nosocomial candidemia using RAPD-PCR technique. Rev Soc Bras Med Trop, v. 39, p. 174-8, 2006.
63. VIUDES, A. et al. Candidemia at a terciary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Microbiol Infec Dis, v. 21, p. 767-74, 2002.
64. YIGIT, N.; AKTAS, E. Comparison of the efficacy of different blood médium in determining the hemolytic activity of Candida species. J Mycol Médical, v. 19, p. 110-5, 2009.